WebJun 23, 2022 · IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the trea IconOVir …
See Also: Tech Support Preview / Show details
WebMay 20, 2021 · Contacts Company Contact: Ben Stone ben@iconovir.com 1-858-224-1900 Investor Contact: Hannah Deresiewicz Stern Investor Relations, Inc.
See Also: Contact Support Preview / Show details
WebDavid D. Chang is a co-founder and Chairman of the Board of Directors of IconOVir Bio. He is a co-founder and currently serves as the President and Chief Executive Officer of …
See Also: Office Preview / Show details
WebIconOVir Bio 1,999 followers on LinkedIn. Pushing the envelope: Our mission is to cure cancer and restore life to every patient everywhere IconOVir Bio is a preclinical-stage …
See Also: Phone Number Preview / Show details
WebMar 20, 2023 · A Executive Assistant at IconOVir Bio Jaclyn Taylor is an Executive Assistant at IconOVir Bio based in San Diego, California. Previously, Jaclyn was an …
See Also: Phone Number Preview / Show details
WebWhat are your colleagues talking about? Find your private company bowl on Fishbowl, join the hottest conversation with your colleagues anonymously. Join the Conversation …
See Also: Phone Number Preview / Show details
WebJul 12, 2023 · IconOVir Bio has dosed the first patient in its Phase I dose escalation and expansion clinical trial of ICVB-1042 to treat advanced solid tumours.. The open-label …
See Also: Phone Number Preview / Show details
WebJul 11, 2023 · IconOVir Bio Announces First Patient Dosed in Phase 1 Clinical Trial of its Lead Product Candidate, ICVB-1042 July 11, 2023 at 8:00 AM · 3 min read -- ICVB-1042 …
See Also: Phone Number Preview / Show details